These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

241 related articles for article (PubMed ID: 35584557)

  • 1. Impact of duration of critical illness and level of systemic glucocorticoid availability on tissue-specific glucocorticoid receptor expression and actions: A prospective, observational, cross-sectional human and two translational mouse studies.
    Téblick A; Van Dyck L; Van Aerde N; Van der Perre S; Pauwels L; Derese I; Debaveye Y; Wouters PJ; Vanhorebeek I; Langouche L; Van den Berghe G
    EBioMedicine; 2022 Jun; 80():104057. PubMed ID: 35584557
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Differential expression of 11beta-hydroxysteroid dehydrogenase types 1 and 2 mRNA and glucocorticoid receptor protein during mouse embryonic development.
    Thompson A; Han VK; Yang K
    J Steroid Biochem Mol Biol; 2004 Apr; 88(4-5):367-75. PubMed ID: 15145446
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Tissue-specific adaptive levels of glucocorticoid receptor alpha mRNA and their relationship with insulin resistance.
    Castro RB; Longui CA; Faria CD; Silva TS; Richeti F; Rocha MN; Melo MR; Pereira WL; Chamlian EG; Rivetti LA
    Genet Mol Res; 2012 Nov; 11(4):3975-87. PubMed ID: 23212335
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Reciprocal regulation of 11β-hydroxysteroid dehydrogenase 1 and glucocorticoid receptor expression by dexamethasone inhibits human coronary artery smooth muscle cell proliferation in vitro.
    Michas G; Liberman M; Becker KC; Handy DE; Loscalzo J; Leopold JA
    Mol Cell Biochem; 2011 Jan; 346(1-2):69-79. PubMed ID: 20922465
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Regulation of glucocorticoid receptor alpha and beta isoforms and type I 11beta-hydroxysteroid dehydrogenase expression in human skeletal muscle cells: a key role in the pathogenesis of insulin resistance?
    Whorwood CB; Donovan SJ; Wood PJ; Phillips DI
    J Clin Endocrinol Metab; 2001 May; 86(5):2296-308. PubMed ID: 11344242
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Regulation of 11β-HSD1 by GH/IGF-1 in key metabolic tissues may contribute to metabolic disease in GH deficient patients.
    Morgan SA; Berryman DE; List EO; Lavery GG; Stewart PM; Kopchick JJ
    Growth Horm IGF Res; 2022 Feb; 62():101440. PubMed ID: 34814007
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Retinoic acid reduces glucocorticoid sensitivity in C2C12 myotubes by decreasing 11beta-hydroxysteroid dehydrogenase type 1 and glucocorticoid receptor activities.
    Aubry EM; Odermatt A
    Endocrinology; 2009 Jun; 150(6):2700-8. PubMed ID: 19179438
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Increased glucocorticoid receptor expression in human skeletal muscle cells may contribute to the pathogenesis of the metabolic syndrome.
    Whorwood CB; Donovan SJ; Flanagan D; Phillips DI; Byrne CD
    Diabetes; 2002 Apr; 51(4):1066-75. PubMed ID: 11916927
    [TBL] [Abstract][Full Text] [Related]  

  • 9. 11beta-hydroxysteroid dehydrogenase type 1 regulates glucocorticoid-induced insulin resistance in skeletal muscle.
    Morgan SA; Sherlock M; Gathercole LL; Lavery GG; Lenaghan C; Bujalska IJ; Laber D; Yu A; Convey G; Mayers R; Hegyi K; Sethi JK; Stewart PM; Smith DM; Tomlinson JW
    Diabetes; 2009 Nov; 58(11):2506-15. PubMed ID: 19675138
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Tissue mRNA expression of the glucocorticoid receptor and its splice variants in fatal critical illness.
    Peeters RP; Hagendorf A; Vanhorebeek I; Visser TJ; Klootwijk W; Mesotten D; Wouters PJ; Koper JW; de Jong FH; Feelders RA; Lamberts SW; Van den Berghe G
    Clin Endocrinol (Oxf); 2009 Jul; 71(1):145-53. PubMed ID: 19178514
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Increased glucocorticoid receptor and 11{beta}-hydroxysteroid dehydrogenase type 1 expression in hepatocytes may contribute to the phenotype of type 2 diabetes in db/db mice.
    Liu Y; Nakagawa Y; Wang Y; Sakurai R; Tripathi PV; Lutfy K; Friedman TC
    Diabetes; 2005 Jan; 54(1):32-40. PubMed ID: 15616008
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Suppression of the Nrf2-dependent antioxidant response by glucocorticoids and 11β-HSD1-mediated glucocorticoid activation in hepatic cells.
    Kratschmar DV; Calabrese D; Walsh J; Lister A; Birk J; Appenzeller-Herzog C; Moulin P; Goldring CE; Odermatt A
    PLoS One; 2012; 7(5):e36774. PubMed ID: 22606287
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Expression of genes related to glucocorticoid action in human subcutaneous and omental adipose tissue.
    Veilleux A; Laberge PY; Morency J; Noël S; Luu-The V; Tchernof A
    J Steroid Biochem Mol Biol; 2010 Oct; 122(1-3):28-34. PubMed ID: 20206259
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Increased expression of 11beta-hydroxysteroid dehydrogenase type 1 in type 2 diabetic myotubes.
    Abdallah BM; Beck-Nielsen H; Gaster M
    Eur J Clin Invest; 2005 Oct; 35(10):627-34. PubMed ID: 16178882
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Enhancement of glucocorticoid-induced 11beta-hydroxysteroid dehydrogenase type 1 expression by proinflammatory cytokines in cultured human amnion fibroblasts.
    Sun K; Myatt L
    Endocrinology; 2003 Dec; 144(12):5568-77. PubMed ID: 12960005
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Is the metabolic syndrome an intracellular Cushing state? Effects of multiple humoral factors on the transcriptional activity of the hepatic glucocorticoid-activating enzyme (11beta-hydroxysteroid dehydrogenase type 1) gene.
    Iwasaki Y; Takayasu S; Nishiyama M; Tsugita M; Taguchi T; Asai M; Yoshida M; Kambayashi M; Hashimoto K
    Mol Cell Endocrinol; 2008 Mar; 285(1-2):10-8. PubMed ID: 18313835
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Tissue specific regulation of glucocorticoids in severe obesity and the response to significant weight loss following bariatric surgery (BARICORT).
    Woods CP; Corrigan M; Gathercole L; Taylor A; Hughes B; Gaoatswe G; Manolopoulos K; Hogan AE; O'Connell J; Stewart PM; Tomlinson JW; O'Shea D; Sherlock M
    J Clin Endocrinol Metab; 2015 Apr; 100(4):1434-44. PubMed ID: 25603461
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The expression of omental 11β-HSD1 is not increased in severely obese women with metabolic syndrome.
    Michalaki M; Kyriazopoulou V; Antonacopoulou A; Koika V; Nikolaou M; Tsoukas A; Kalfarentzos F; Vagenakis AG; Voukelatou G; Papavassiliou AG
    Obes Facts; 2012; 5(1):104-11. PubMed ID: 22433622
    [TBL] [Abstract][Full Text] [Related]  

  • 19. 11β-Hydroxysteroid dehydrogenase type 1 shRNA ameliorates glucocorticoid-induced insulin resistance and lipolysis in mouse abdominal adipose tissue.
    Wang Y; Yan C; Liu L; Wang W; Du H; Fan W; Lutfy K; Jiang M; Friedman TC; Liu Y
    Am J Physiol Endocrinol Metab; 2015 Jan; 308(1):E84-95. PubMed ID: 25389364
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Ultraviolet radiation regulates cortisol activity in a waveband-dependent manner in human skin ex vivo.
    Skobowiat C; Sayre RM; Dowdy JC; Slominski AT
    Br J Dermatol; 2013 Mar; 168(3):595-601. PubMed ID: 23363016
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.